JP2005500325A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500325A5
JP2005500325A5 JP2003511875A JP2003511875A JP2005500325A5 JP 2005500325 A5 JP2005500325 A5 JP 2005500325A5 JP 2003511875 A JP2003511875 A JP 2003511875A JP 2003511875 A JP2003511875 A JP 2003511875A JP 2005500325 A5 JP2005500325 A5 JP 2005500325A5
Authority
JP
Japan
Prior art keywords
group
independently
formula
compound
chelating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003511875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500325A (ja
JP5015409B2 (ja
Filing date
Publication date
Priority claimed from GBGB0116815.2A external-priority patent/GB0116815D0/en
Application filed filed Critical
Publication of JP2005500325A publication Critical patent/JP2005500325A/ja
Publication of JP2005500325A5 publication Critical patent/JP2005500325A5/ja
Application granted granted Critical
Publication of JP5015409B2 publication Critical patent/JP5015409B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003511875A 2001-07-10 2002-07-10 改良キレート剤結合体 Expired - Lifetime JP5015409B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0116815.2A GB0116815D0 (en) 2001-07-10 2001-07-10 Improved chelator conjugates
GB0116815.2 2001-07-10
PCT/GB2002/003168 WO2003006070A2 (en) 2001-07-10 2002-07-10 Improved chelator conjugates

Publications (3)

Publication Number Publication Date
JP2005500325A JP2005500325A (ja) 2005-01-06
JP2005500325A5 true JP2005500325A5 (enExample) 2006-01-05
JP5015409B2 JP5015409B2 (ja) 2012-08-29

Family

ID=9918227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003511875A Expired - Lifetime JP5015409B2 (ja) 2001-07-10 2002-07-10 改良キレート剤結合体

Country Status (20)

Country Link
US (2) US7597875B2 (enExample)
EP (1) EP1404377B1 (enExample)
JP (1) JP5015409B2 (enExample)
KR (1) KR100892009B1 (enExample)
CN (4) CN101537190A (enExample)
AT (1) ATE304866T1 (enExample)
AU (1) AU2002317317B2 (enExample)
BR (1) BR0210965A (enExample)
CA (1) CA2450690C (enExample)
DE (1) DE60206272T2 (enExample)
DK (1) DK1404377T3 (enExample)
ES (1) ES2250671T3 (enExample)
GB (1) GB0116815D0 (enExample)
HU (1) HU228850B1 (enExample)
IL (1) IL159388A0 (enExample)
MX (1) MXPA04000210A (enExample)
NO (1) NO334093B1 (enExample)
RU (1) RU2298012C2 (enExample)
WO (1) WO2003006070A2 (enExample)
ZA (1) ZA200400143B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2433657A1 (en) * 2001-01-05 2002-07-11 Duke University Contrast enhancement agent for magnetic resonance imaging
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
GB0416062D0 (en) 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
US7431914B2 (en) 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
CN1925876A (zh) * 2004-03-04 2007-03-07 通用电气医疗集团股份有限公司 用于诊断和治疗的血管紧张素肽类似物和螯合剂的缀合物
AU2005307195A1 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
US20080226555A1 (en) * 2005-06-08 2008-09-18 Bengt Langstrom Method for the Use of [11C] Carbon Monoxide in Labeling Synthesis of 11C-Labelled Esters and Acids by Sensitized Photo-Induced Free Radical
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
DE602007012208D1 (de) 2006-02-15 2011-03-10 Ge Healthcare As Kontrastmittel
US7943117B2 (en) * 2006-06-08 2011-05-17 Atomic Energy Council—Institute of Nuclear Research Method for testing radiochemical purity of Tc-99m-TRODAT-1
WO2008072973A2 (en) * 2006-12-11 2008-06-19 Ge Healthcare As Radiolabelled peptide based compounds and uses thereof
ES2712881T3 (es) 2008-12-02 2019-05-16 Univ Melbourne Conjugados macrocíclicos que contienen nitrógeno como radiofármacos
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
ES2804509T3 (es) 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201110767D0 (en) 2011-06-24 2011-08-10 Ge Healthcare Ltd Infection imaging
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
CA2901231C (en) * 2013-02-15 2020-06-23 Thomas Jefferson University Kit comprising lyophilized compositions for tumor imaging
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
US11033642B2 (en) 2014-03-19 2021-06-15 Universitat Zurich Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy
CN112840025A (zh) * 2018-05-08 2021-05-25 迈阿密大学 用于将治疗性核酸递送到组织的材料方法
CN112105393A (zh) 2018-05-16 2020-12-18 爱默蕾大学 苯乙烯基苯并噻唑衍生物及在成像中的用途
CN111548275A (zh) * 2020-05-27 2020-08-18 龙曦宁(上海)医药科技有限公司 一种2-(氨基甲基)-n1,n1-二甲基丙烷-1,3-二胺三盐酸盐的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1588978A (en) * 1977-07-19 1981-05-07 Ici Ltd Coating processes
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
US5997843A (en) * 1993-08-04 1999-12-07 Amersham International Plc Radiometal complexes that localise in hypoxic tissue
CA2156605A1 (en) * 1994-01-12 1995-07-20 Bracco International B.V. Ligands and metal complexes thereof
CA2179990A1 (en) * 1994-01-12 1995-07-20 Gary Robert Bower Biological targeting agents
RU2205186C2 (ru) * 1998-05-15 2003-05-27 Амершам Плк Меченые аналоги глутамина и лизина
US6783711B2 (en) * 2000-05-23 2004-08-31 Ge Osmonics, Inc. Process for preparing a sulfonamide polymer matrix
US6988794B2 (en) * 2001-03-08 2006-01-24 Matsushita Electric Industrial Co., Ltd. Inkjet recording ink, method for producing said ink, and ink cartridge and recording device having said ink

Similar Documents

Publication Publication Date Title
RU2003137592A (ru) Улучшенные хелатные конъюгаты
JP2023535365A5 (enExample)
JP2006507265A5 (enExample)
JP2005053931A5 (enExample)
PE20090611A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
JP2010514786A5 (enExample)
JP2008509166A5 (enExample)
JP2004533444A5 (enExample)
EP2311851A3 (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
JP2005511697A5 (enExample)
JP2008533191A5 (enExample)
JP2002508375A5 (enExample)
JP2010524965A5 (enExample)
EP2308828A3 (en) CaSR antagonist
HRP20121026T1 (hr) Postupak za dobivanje kaspofungina i njegovih intermedijera
JP2005536503A5 (enExample)
JP2002512989A5 (enExample)
JP2001261662A5 (enExample)
CA2530584A1 (en) Composition and method for diversion agents for acid stimulation of subterranean formations
WO2019213662A1 (en) Non-peptidic cell-penetrating motifs
JP2004529172A5 (enExample)
JP2012518649A5 (enExample)
JP2004538278A5 (enExample)
JP2005514512A5 (enExample)
JP2005516898A5 (enExample)